tDCS for Cognitive Improvement in Healthy Subjects
Trial Summary
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it excludes those with a history of treatment with psychotropic medication (drugs affecting mood, perception, or behavior).
What data supports the effectiveness of the treatment Transcranial Direct Current Stimulation (tDCS) for cognitive improvement in healthy subjects?
Is transcranial direct current stimulation (tDCS) safe for humans?
How does tDCS differ from other treatments for cognitive improvement in healthy subjects?
Transcranial direct current stimulation (tDCS) is unique because it uses a weak electric current applied through the scalp to modulate brain activity, which is different from traditional cognitive enhancement methods that might rely on drugs or behavioral interventions. Unlike other treatments, tDCS is non-invasive and can be administered repeatedly over multiple sessions to potentially enhance cognitive functions like working memory and executive functions.1231112
What is the purpose of this trial?
The purpose of this study is to better understand the neural correlates of higher-order cognition, both in the healthy brain and in schizophrenia, and to determine how these mechanisms are modulated by transcranial direct current stimulation (tDCS) at frontal and occipital scalp sites. Testing the effects of tDCS at these scalp sites on cognitive task performance will help us understand the roles of the brain regions corresponding to these sites during higher-order cognitive processing (language comprehension, cognitive control, and related attention and memory processes). Behavioral and electrophysiological (EEG) measures will be used to assess cognitive performance. Our overarching hypothesis is that stimulating prefrontal circuits with tDCS can improve cognitive control performance, and ultimately performance on a range of cognitive tasks, as compared to stimulating a different cortical region (occipital cortex) or using sham stimulation.This study is solely intended as basic research in order to understand brain function in healthy individuals and individuals with schizophrenia. This study is not intended to diagnose, cure or treat schizophrenia or any other disease.
Eligibility Criteria
This trial is for healthy individuals aged 18-50 who speak and understand English well enough to complete cognitive tasks. They must be able to consent to the study. People with head trauma, psychotropic medication use, poor vision without correction, or conditions that contraindicate tDCS/MRI (like pregnancy or metal in the body) cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex or occipital cortex, or sham stimulation
Follow-up
Participants are monitored for cognitive performance using behavioral and electrophysiological measures
Treatment Details
Interventions
- Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor